A new class of anticoagulant drugs on the horizon is taking takes fresh aim at one of cardiology’s toughest challenges: how to preventing blood clots that cause heart attacks and strokes, without leaving patients at risk of bleeding.
Morris Chang had decades of experience before he founded a business that’s indispensable to the global economy. What can other middle-aged entrepreneurs learn from him?